TY - JOUR
T1 - Bilateral blindness due to anti-tubercular treatment
T2 - A rare presentation
AU - Bhandary, Sulatha V.
AU - Sehgal, Akshay
AU - Rao, Lavanya G.
AU - Krishna Rao, A.
AU - Kusumgar, Pallak
AU - Thanusubramanian, Harish
N1 - Publisher Copyright:
© 2016, Innovare Academics Sciences Pvt. Ltd. All rights reserved.
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Ethambutol and isoniazid (INH) are antimicrobial agents used in the treatment of tuberculosis. Optic neuropathy is a well-recognized toxic effect of these drugs, usually manifesting as a decrease in visual acuity and deficits in color vision. This study presents the case of a 75-year-old male diagnosed of spinal tuberculosis, who developed irreversible bilateral optic neuropathy causing complete blindness induced by ethambutol and INH. Ophthalmologic examination revealed sluggish pupillary reactions and optic disc pallor in both eyes. Visual evoked potential and magnetic resonance imaging brain complemented the confirmation of the diagnosis.
AB - Ethambutol and isoniazid (INH) are antimicrobial agents used in the treatment of tuberculosis. Optic neuropathy is a well-recognized toxic effect of these drugs, usually manifesting as a decrease in visual acuity and deficits in color vision. This study presents the case of a 75-year-old male diagnosed of spinal tuberculosis, who developed irreversible bilateral optic neuropathy causing complete blindness induced by ethambutol and INH. Ophthalmologic examination revealed sluggish pupillary reactions and optic disc pallor in both eyes. Visual evoked potential and magnetic resonance imaging brain complemented the confirmation of the diagnosis.
UR - http://www.scopus.com/inward/record.url?scp=84991392582&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84991392582&partnerID=8YFLogxK
U2 - 10.22159/ajpcr.2016.v9s2.11823
DO - 10.22159/ajpcr.2016.v9s2.11823
M3 - Article
AN - SCOPUS:84991392582
SN - 0974-2441
VL - 9
SP - 1
EP - 2
JO - Asian Journal of Pharmaceutical and Clinical Research
JF - Asian Journal of Pharmaceutical and Clinical Research
ER -